Clinical and Molecular Hepatology

Korean Association for the Study of the Liver

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Clinical and Molecular Hepatology is an open-access journal published by Korean Association for the Study of the Liver in South Korea, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 2,000,000 KRW. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Korean Association for the Study of the Liver
ISSN
2287-2728 · 2287-285X
Country
South Korea
Languages
english
Access
Open access
Declared publication charge
2,000,000 KRW
Articles in DOAJ
1386
Declared review time
10 weeks
Declared peer-review model
peer_review
Official website
http://www.e-cmh.org

Index listings

  • DOAJ · 2017-07-28
  • MEDLINE · 2012-01-01
Indexing
DOAJ · MEDLINE
APC
2,000,000 KRW
Declared review time (DOAJ)
10 weeks
Actual review time (measured)
17 days received→accepted — computed from PubMed (n=99)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1386

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

10weeks

Works in OpenAlex

2101

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

83

i10-index

622

From OpenAlex open data (CC0).

Editorial & policy10
Last DOAJ review date
2025-03-21
Added to DOAJ
2017-07-28
Declared plagiarism screening
Declared
Other fees beyond APC
Yes
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
95%
ORCID iDs in current deposits
95%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity3
Alternate titles
CMH
Source type
journal
NLM unique ID (PubMed)
101586730
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology

LCC codes

RC799-869

Subject areas

  • Liver Disease Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Liver Disease and Transplantation
Show all subjects (50)
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Legal and Regulatory Analysis
  • Military Technology and Strategies
  • Legal and Regulatory Analysis
  • Linguistic, Cultural, and Literary Studies
  • Military Technology and Strategies
  • Linguistic, Cultural, and Literary Studies
  • Alcohol Consumption and Health Effects
  • Alcohol Consumption and Health Effects
  • Diet, Metabolism, and Disease
  • Diet, Metabolism, and Disease
  • Organ Transplantation Techniques and Outcomes
  • Organ Transplantation Techniques and Outcomes
  • Liver Diseases and Immunity
  • Liver Diseases and Immunity
  • Hepatitis Viruses Studies and Epidemiology
  • Hepatitis Viruses Studies and Epidemiology
  • Liver physiology and pathology
  • Liver physiology and pathology
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Diet and metabolism studies
  • Diet and metabolism studies
  • Drug-Induced Hepatotoxicity and Protection
  • Drug-Induced Hepatotoxicity and Protection
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • HIV/AIDS drug development and treatment
  • HIV/AIDS drug development and treatment
  • Pediatric Hepatobiliary Diseases and Treatments
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Gallbladder and Bile Duct Disorders
  • Endoplasmic Reticulum Stress and Disease
  • Endoplasmic Reticulum Stress and Disease

Keywords (DOAJ)

  • biliary tract diseases
  • liver diseases

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: